LifeStance Health Group, Inc. (LFST) FY2025 10-K Annual Report
LifeStance Health Group, Inc. (LFST) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 25, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
LifeStance Health Group, Inc. FY2025 10-K Analysis
Business Overview
- • Core business: Nationwide outpatient mental healthcare platform employing 8,040 clinicians across 33 states with integrated virtual and in-person care
- • Strategic shift: Prioritized virtual visits leading to significant reduction of physical office footprint and closure of underoccupied centers in 2023
- • Quantitative metric: 1.0 million unique patients treated in 2025 through approximately 9.0 million visits, with 87% having two or more visits
- • Emphasis on integrated care: Over 13 active integrated care programs partnering with primary care and specialists to unify mental and physical healthcare
- • Noteworthy fact: 90% of revenue derived from commercial in-network payors, enhancing affordability and access through extensive payor contracts
Management Discussion & Analysis
- • Cash and cash equivalents $248.6M in 2025 vs $154.6M in 2024; operating cash flow $146.2M in 2025 vs $107.3M in 2024
- • Debt outstanding $282.8M in 2025 vs $290.0M in 2024 under 2024 Credit Agreement; compliance with leverage and interest coverage covenants
- • Investing cash outflow $36.1M for property and equipment in 2025 vs $21.6M in 2024; financing activities used $16.0M in 2025 vs $9.9M in 2024 due to loan repayments and equity award settlements
- • No explicit revenue or profit margins disclosed in excerpt; reported $9.7M net income in 2025 vs $57.4M net loss in 2024 mentioned in cash flow section
- • Management expects existing cash sufficient for 12 months; growth, acquisitions, and market expansion are key risks requiring potential additional financing
Risk Factors
- • Regulatory risk from the No Surprises Act (effective Jan 1, 2022) causing payment disputes and penalties for billing and provider directory inaccuracies
- • Geopolitical/macroeconomic exposure from 29% revenue concentration with UnitedHealthcare (14%) and Elevance Health (15%), risking impact from reimbursement changes
- • Operational vulnerability in clinician recruitment and retention amid rising labor costs and potential unionization increasing expenses and turnover
- • Competitive threat from emerging AI and machine learning technologies reducing demand for licensed clinician care, impacting patient volumes
- • Financial risk from high capital expenditures on new centers leading to margin pressure until patient visits generate revenue
LifeStance Health Group, Inc. FY2025 Key Financial MetricsXBRL
Revenue
$1.4B
▲ +13.9% YoY
Net Income
$10M
▲ +116.8% YoY
Operating Margin
1.7%
▲ +422bp YoY
Net Margin
0.7%
▲ +527bp YoY
ROE
0.6%
▲ +461bp YoY
Total Assets
$2.2B
▲ +4.0% YoY
Operating Cash Flow
$146M
▲ +36.3% YoY
Source: XBRL data from LifeStance Health Group, Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on LifeStance Health Group, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.